HIGHLIGHTS
- who: Yutaka Fukaya et al. from the University of Louisiana at Monroe, United States have published the research work: Development of a population pharmacokinetics and pharmacodynamics model of glucarpidase rescue treatment after high-dose methotrexate therapy, in the Journal: (JOURNAL)
- what: The authors aimed to develop a CPG2 population pharmacokinetics (popPK) analysis in healthy volunteers and a popPK and pharmacodynamics (PD) analysis (popPK-PD) in patients who received CPG2 rescue for delayed MTX excretion.
- how: The authors conducted a phase 1 study in which two doses of CPG2 (50 and 20 U/kg . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.